Clinical Trial: Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase II Dose Escalation Study of Caspofungin in Patients With Invasive Aspergillosis

Brief Summary: This study investigates the safety and tolerability as well as the efficacy and pharmacokinetics of caspofungin in four escalating dosages in adult patients with hematologic malignancies and proven or probable invasive aspergillosis.